Bure has divested shares in Mycronic AB (publ)

Bure Equity AB (publ) ("Bure") has sold 7,800,000 shares in Mycronic AB (publ) ("Mycronic") to Swedish and International investors.

Following the placing, Bure owns 29,317,163 shares in Mycronic corresponding to 29.9 per cent of the capital and votes.

   
Bure Equity AB (publ)

     
For additional information, please contact:
Henrik Blomquist, CEO

Tel. +46 8 – 614 00 20

   

The information contained herein is subject to the disclosure requirements of Bure Equity AB under the Swedish Securities Market Act. The information has been publicly communicated on 20 November 2015, 08:30 CET.

Tags:

About Us

Bure is a long-term principal owner of operating companies. By actively developing a diversified portfolio of companies and operations, Bure’s objective is to create value and returns for its shareholders.

Subscribe

Documents & Links